Immunome Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Issuer Purchases of Equity Securities ​ ​ ​ ​ ​ ​ ​ (a) (b) ​ ​ Total number ​ Average price ​ ​ of shares (or units) ​ paid per share Period ​ purchased ​ (or unit) January 1, 2025 - January 31, 2025 ​ — ​ $ — February 1, 2025 - February 28, 2025 ​ — ​ ​ — March 1, 2025 - March 31, 2025 (1) ​ 19,093 ​ ​ 9.22 Total ​ 19,093 ​ $ 9.22 (1) The number of shares reported reflects a deemed surrender of shares in connection with a stock swap transaction to cover the exercise price of employee stock options. The deemed price paid was the closing price of our common stock on the Nasdaq Capital Market on the date of exercise. Item 3. Defaults Upon Senior Securities None. Item 4. Mine and Safety Disclosures Not applicable.